Your browser doesn't support javascript.
loading
BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate.
Cherney, Robert J; Anjanappa, Prakash; Selvakumar, Kumaravel; Batt, Douglas G; Brown, Gregory D; Rose, Anne V; Vuppugalla, Ragini; Chen, Jing; Pang, Jian; Xu, Songmei; Yarde, Melissa; Tebben, Andrew J; Paidi, Venkatram Reddy; Cvijic, Mary Ellen; Mathur, Arvind; Barrish, Joel C; Mandlekar, Sandhya; Zhao, Qihong; Carter, Percy H.
Afiliação
  • Cherney RJ; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Anjanappa P; Biocon Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Selvakumar K; Biocon Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Batt DG; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Brown GD; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Rose AV; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Vuppugalla R; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Chen J; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Pang J; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Xu S; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Yarde M; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Tebben AJ; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Paidi VR; Biocon Bristol Myers Squibb Research and Development Center, Bangalore 560099, India.
  • Cvijic ME; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Mathur A; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Barrish JC; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Mandlekar S; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Zhao Q; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
  • Carter PH; Bristol Myers Squibb Company, Research and Early Development, Princeton, New Jersey 08540-4000, United States.
ACS Med Chem Lett ; 12(11): 1753-1758, 2021 Nov 11.
Article em En | MEDLINE | ID: mdl-34795864

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos